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Abstract: Rapid detection of Methicillin Resistant Staphylococcus aureus (MRSA) is an important 
concern for both treatment and implementation of infection control policies. The present study 
provides an ‘in house’ real-time PCR assay to detect directly nuc, pvl, and mecA genes. The assay is 
able to perform identification of MRSA, Methicillin-Sensitive S. aureus, Methicillin-Resistant 
Coagulase Negative Staphylococci and the Panton-Valentine leukocidin virulence gene from rectal 
and pharyngeal swab samples in a screening context. We found an analytical sensitivity of this 
current Triplex PCR assay of 514 CFU/mL. Analytical specificity was tested with different Gram-
positive and Gram-negative species and yielded no false-positive PCR signal. The sensitivity and 
specificity of the Triplex Real Time PCR were both 100% for these targets when compared with the 
culture and conventional methods. This assay is readily adaptable for routine use in a microbiology 
laboratory, as it will enable the implementation of timely and properly guided therapy and infection 
control strategies.  
Keywords: Staphylococcus aureus; Real-time PCR; Panton Valentine Leucocidin; MRSA; nuc gene; 
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Abbreviations: MRSA: Methicillin resistant Staphylococcus aureus; MSSA: Methicillin susceptible 
Staphylococcus aureus; MRCoNS: Methicillin reistant Coagulase Negative Staphilococci; PVL: 
Panton valentine leucocidin; PCR: Polymerase chain reaction; CFU: Colonies forming unit; PBP2a: 
Penicillin binding protein 2a 
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1. Introduction  
Staphylococcus aureus plays an important role as human pathogen causing a wide range of 
infections and is a major cause of nosocomial infections [1]. MRSA has emerged as an important 
public health concern, causing significant morbidity, mortality and prolonged hospitalization and a 
trend of increasing prevalence in numerous countries and regions. MRSA strains differ from 
methicillin-sensitive S. aureus (MSSA) strains due to the insertion of the staohylococcal cassette 
chromosome mec (SCCmec) into on the chromosome gene orfX of the staphylococcal cassette 
chromosome mec (SCCmec). The SCCmec element is a mobile genetic element, which harbors the 
single determinant for methicillin resistance, namely the mecA or mecC gene. These genes encode 
PBP2a enzymes that have low affinity for all β-lactams, except for the fifth generation 
cephalosporins such as ceftaloridine or ceftobiprole. Acquisition of mecA renders β-lactams useless 
against MRSA and alternative therapies need to be used in serious infections.  
MRSA strains can be distinguished between in hospital-acquired (HA-MRSA) and community-
acquired (CA-MRSA). CA-MRSA strains are reported to belong to SCCmec type IV, V, or VI. 
Compared to HA-MRSA strains, CA-MRSA are usually susceptible to macrolides and 
fluoroquinolones antibiotics and may produce Panton-Valentine leucocidin (PVL).  
PVL, a two component cytotoxin able to form pores that destroy leukocytes [2], accounts also 
for the high virulence potential of CA-MRSA [3] and may also induce expression of other virulence 
factors [4]. S. aureus strains producing PVL are involved in skin and soft tissue infections (SSTIs), 
necrotizing pneumonia [5] and osteomyelitis [6–8]. 
Rapid detection of MRSA is imperative for both treatment and implementation of infection control 
policies to prevent disease spread and outbreaks [9]. Molecular methods, including polymerase chain 
reaction (PCR) and real-time PCR, have been used for rapid MRSA identification [10]. PVL real-time 
PCR assay was also developed [11]. Fast and accurate identification of S. aureus [12] and detection 
of methicillin resistance are crucial for immediate treatment with effective antibiotics, which will 
result in decreased morbidity and mortality rates [13]. Moreover, the PVL locus is a virulence factor, 
useful for molecular diagnosis [14].  
In addition to S. aureus, coagulase negative staphylococci (CoNS) have also become increasingly 
important in recent years. They are particularly associated with the use of indwelling or implanted foreing 
bodies. Moreover a large proportion of CoNS resulted methicillin resistant (MRCoNS) harbouring the 
mecA gene [15] 
The present study describes an ‘in house’ triplex PCR assay developed to identify and 
differentiate MRSA (Methicillin-Resistant S. aureus), MSSA (Methicillin- Sensitive S. aureus), 
MRCoNS (Methicillin-Resistant Coagulase Negative Staphylococci) and to detect the Panton-
Valentine leukocidin virulence gene, directly from clinical samples even heavy contaminated as 
rectal or pharyngeal swabs. 
2. Materials and methods 
A multiplex TaqMan PCR method for the detection of PVL-encoding genes, mecA (for 
detection of methicillin resistance) and nuc (for identification of S. aureus) genes was initially 
developed using reference strains, S. aureus ATCC 25913 (MSSA) and ATCC 700699 (MRSA). 
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Both strains were incubated for 24 h on Mannitol Salt Agar (MSA) plates. Nucleic acids were 
extracted with a Microlab Nimbus apparatus (Hamilton Robotics, NV, USA) from 350 μl of 0.5 McF 
suspension according to the manufacturer’s instructions and recovered in 100 μl of elution buffer. 
The nucleotide sequence of mecA, pvl and nuc genes of S. aureus were obtained from the 
GenBank® database and used in the design of primer and probe sequences (Table 1) which were 
evaluated for specificity using the standard nucleotide comparison tool: BLASTN 
(www.ncbi.nlm.nih.gov). The probes were labeled with three different fluorescent dyes (FAM, VIC, 
NED) at the 5’ end and included a minor groove binder molecule and non fluorescent quencer (MGB-
NFQ) at the 3’ end. 
Table 1. primers and probes used for Real-time PCR. 
Target  GenBank® 
Accession 
number 






mecA fw CAATGCCAAAATCTCAGGTAAAGTG 1931–1957  









pvl fw AAATGCTGGACAAAACTTCTTGG 606–624  








nuc fw  GGCATATGTATGGCAATTGTTTC 25–48  




The 25 µl reaction mixture contained 10 µl of DNA template, 2.5 µl of primers (900nM) and 
probe (250 nM), 12.5 µl 2X Master mix (Applied Biosystem CA, USA) Multiplex real-time PCR 
was performed on an ABI 7500 real-time PCR system (Applied Biosystems). 
Thermocycler conditions consisted of an initial denaturation at 94 ℃ for 5 min, followed by 
amplification that was performed during 38 cycles of denaturation at 95 ℃ for 15 sec and 
annealing/extension at 60 ℃ for 30 sec. Multiple fluorescent signals were obtained once per cycle 
upon completion of extension step. Data acquisition and analysis of the real-time PCR assay were 
performed using ABI 7500 real-time PCR system (Applied Biosystems). Figure 1 shows an example 
of the amplification plot of the three genes using the S. aureus MDR1305 as representative strain.  
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Figure 1. Amplification plot obtained with a detection system based on the use of three 
fluorophores with strain S. aureus MDR1305: FAM (red line) for the detection of mecA 
gene, VIC (blue line) for the detection of pvl gene and NED (green line) for the detection 
of nuc gene. 
The Real-Time protocol was confirmed with 40 S. aureus strains, either MRSA (25) and MSSA (15) 
and 4 S. aureus strains producing PVL (including in MRSA group), identify by conventional culture 
method and by endpoint PCR for methicillin resistance and pvl gene. The specificity was checked 
using other Staphylococcus spp strains, other Gram-positive and Gram-negative. All S. aureus strains 
were recognized by amplification of the nuc gene, while there was no amplification of this gene by 
other Staphylococcus spp, or other bacteria species.  
The analytical sensitivity was evaluated using serial dilutions of cell stocks. The sensitivity 
of the assay was evaluated using 2 MRSA clinical isolates, 2 MSSA clinical isolates, and the 
reference strains ATCC 25923 (MSSA) and ATCC 700699 (MRSA). A serial dilution of cultured 
S. aureus ranging from 5 × 108 to 5 × 10 CFU/ml n NaCl was analyzed. To establish the Limit of 
Detection (LoD), genomic DNA extracted from each dilution was tested in 5 replicates. The lowest 
concentration of serial dilution that yielded positive test results in 95% he replicates were set as the 
LoD (approximately 18 copies/reaction). The analytical sensitivity curve was constructed by plotting 
the S. aureus DNA reference strains input against the corresponding PCR threshold cycle (Ct) values. 
Our assay showed an efficiency > 90% with a correlation coefficient R2  >  0.99. The linearity of this 
assay is detectable in 10-fold scalar dilutions (n = 5 for each dilution) from 5  ×  106 copies/mL to 5  
×  102 copies/mL. To evaluate intra-assay and inter-assay reproducibility, we calculated the 
coefficient of variation (CV) of the threshold cycle (CT) values of serial DNA specific for mecA, 
nucA and pvl target gene in triplicate. We assayed intra-assay analysis with 10-fold serial dilutions 
(from 5  ×  105 copies/mL to 5  ×  102 copies/mL) of the same target DNA. The analysis of 
coefficient of variation (CV) calculated on Ct average was less than 2% for all dilutions of mecA, 
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nucA and pvl DNA target. Figure 2 shows the amplification curves and dilution end point standard 
curves of log10 genome versus Ct cycle number of nuc (green), mecA (red) and pvl (blue) genes. The 
analytic sensitivity of this assay for each gene was approximately 500 CFU/mL. 
 
Figure 2. Amplification curves and dilution end point standard curves of log10 genome 
versus Ct cycle number of nuc (green), mecA (red) and pvl (blue) genes. 
Analytical specificity was evaluated using DNA lysates prepared from 20 phenotypically and 
genotypically well-characterized methicillin sensitive Staphylococcus spp., namely S. haemolyticus (8), S. 
hominis (4), S. epidermidis (8), and 13 other Gram-positive, namely Enterococcus faecalis (9), 
Enterococcus faecium (4), and some Gram-negative strains usually found in rectal swabs such as 
Escherichia coli (20), Proteus vulgaris (8), Enterobacter cloacae (8), Klebsiella pneumoniae (10).  
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Routinely, we screen pharyngeal and rectal swabs, collected using eSwab (Copan, Brescia, 
Italy), for MRSA during surveillance of multi-drug-resistant program. Screening is conducted 
streaking samples on Mannitol Salt Agar plus a cefoxitin disk (30 µg) and Columbia blood agar 
homemade plates with 5% sheep blood. Positive strains were grown for 24 h and identified by 
MALDI-TOF (Bio-Mérieux). The methicillin resistance was tested by Vitek2 (BioMérieux) 
following EUCAST interpretation guidelines. 
A retrospective assay was conducted on 38 pharyngeal and 42 rectal swabs collected from 80 
hospitalized patients. All samples were analyzed in parallel using both culture-based method and PCR-
based analysis (Table S1). Viable bacterial counts were determined after 18 h of growth at 37 ℃. All 
isolates were identified by MALDI-TOF procedure and, subsequently, tested against antimicrobial 
agents through broth micro-dilution procedure and EUCAST interpretation criteria 
(http://www.eucast.breakpoints.org). S. aureus ATCC 25923 and S. aureus ATCC 700699 were used 
as quality control. Methicillin resistant S. aureus isolates carrying the mecA gene were evaluated by cefoxitin 
disk diffusion test (30 μg). According to the Eucast guidelines, a zone of growth inhibition around the 
cefoxitin disk of < 22 mm indicates the presence of mecA gene and the isolate should be reported as MRSA. 
All isolated S. aureus strains were also checked for mecA gene by end-point PCR [16]. 
3. Results and discussion 
The pvl were amplified only by the four S. aureus know to harbor this gene. In the same way 
mecA gene was detected only in the 25 MRSA strains and in the MRCoNS. 
We found an analytical sensitivity of this current Triplex PCR assay of 514 CFU/mL. PCR 
assays, with three replicates per sample, consistently detected MRSA alone at 18 copies per reaction.  
The analytical specificity evaluated with different Staphylococcus spp, Gram positive and 
Gram-negative strains was of 100% since none of the strains used to test specificity amplified nuc, 
pvl and mecA genes and no false positive was registered.  
We applied our triplex RT-PCR assay on 80 clinical samples analyzed in parallel with culture 
method and MALDI-TOF identification, as summarized in Figure 3. No positive samples were 
detected for pvl gene. The agreement between culture method/MALDI-TOF procedure and our 
molecular assay was of 100%. The sensitivity and specificity of the Triplex real time RT-PCR were 
both 100% for these targets when compared with the culture and conventional methods. 
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Figure 3. Results summary of Triplex real time PCR assay applied directly to 80 clinical samples. 
This triplex real time PCR assay is able to simultaneously identify the species, the meticillin 
resistance and the presence of the necrotizing toxin present in the community strains in only one hour, 
directly from the clinical sample, thus reducing reporting times and activating immediately clinical 
therapy or decolonization measures 
The results obtained with the triplex real-time PCR assay were compared with the results from a 
culture method, considered as the standard method. This assay was able to differentiate between S. 
aureus and CoNS. In addition, the triplex real time PCR assay differentiates methicillin-susceptible 
and methicillin-resistant strains and the presence of PVL toxin gene locus, and detecting nuc, pvl, 
and mecA genes is able to perform identification of MRSA, MSSA, PVL-positive MRSA (PPMRSA), 
PVL-positive MSSA (PPMSSA), methicillin resistant CoNS (MRCoNS). No unrelated Gram-
positive and Gram-negative species yielded any false-positive PCR signal. This assay is readily 
adaptable for use in routine microbiology laboratory, as it will enable the implementation of timely 
and properly guided therapy and infection control strategies. The assay provides a valuable tool for 
the rapid and accurate characterization of staphylococci, as automatic DNA extraction directly from 
sample, amplification cycles and post-PCR analyses are completed in less than 3 hours. Comparing 
to the assay developed by Söderquist et al. [17], our assay doesn’t need to pre-treat clinical samples 
by broth enriched method. Our assay was validate starting directly from heavy contaminated clinical 
samples (rectal swab and pharingeal swab) during multidrug resistant screening program and show a 
very high sensititity and specificity. Okolie et al. [18] developed a pentaplex PCR assay, using the 
spa gene marker indeed of nuc gene for S. aureus detection, that is usually used. Added markers 
were the bacterial marker 16S rRNA and a marker for coagulase-negative staphylococci. The last 
will be a good improvement of our assay. Okolie et al. [18] tested their assay in spiked bloodcultures 
which generally have a higher bacterial load than clinical samples.  
In conclusion, we develop a highly specific and sensitive triplex real-time PCR assay to apply 
directly from clinical swab specimens to detect MRSA, MSSA both in combination with pvl gene 
145 
AIMS Microbiology  Volume 5, Issue 1, 138–146. 
and MRCoNS without any need of broth enrichment step. This assay might be useful in the 
microbiological screening of colonized patients, especially those who need to undergo heart surgery 
and need to be decolonized for staphylococci. 
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